8-K: Artificial Intelligence Technology Solutions Secures Up to $30 Million Equity Financing with GHS Investments

Artificial Intelligence Technology Solutions Inc. has entered into a new two-year equity financing agreement with GHS Investments, LLC, providing access to up to $30 million in capital through common stock sales.

Summary

• Artificial Intelligence Technology Solutions Inc. (AITX) has signed an Equity Financing Agreement with GHS Investments, LLC (GHS) on May 27, 2025, superseding a prior agreement that expired on March 22, 2025.
• The agreement allows AITX to sell up to 2,500,000,000 shares of its common stock to GHS, with an aggregate value not exceeding $30,000,000 over a 24-month term, expiring on May 27, 2027.
• AITX has the discretion to issue 'puts' to GHS, ranging from a minimum of $10,000 to a maximum of $1,500,000 per put, with a minimum of 10 trading days between closings.
• The purchase price for shares is generally 80% of the Market Price (lowest traded price during the 9 preceding trading days).
• If the average closing price for the common stock during the three trading days preceding a Put Notice is equal to or greater than $0.01 per share, the purchase price will be 85% of the Market Price.
• Following an up-list to NASDAQ or an equivalent national exchange, the purchase price will be 90% of the lowest Volume Weighted Average Price (VWAP) during the pricing period, subject to a floor of $2.00 per share.
• GHS Investments, LLC is prohibited from beneficially owning more than 4.99% of AITX's outstanding common stock at any given time.
• The company intends to use the proceeds for general corporate and working capital purposes, as well as potential acquisitions of assets, businesses, or operations.
• A Registration Rights Agreement was also entered into, obligating AITX to file a Form S-1 Registration Statement within 30 calendar days and use best efforts to have it declared effective within 30-90 calendar days.

Sentiment

Score: 6

Explanation: The securing of a significant equity financing facility is a positive for the company's liquidity and operational runway. However, the highly dilutive nature of the terms and the disclosed material weakness in internal accounting controls temper the overall positive sentiment, indicating potential challenges and costs associated with this funding.

Positives

• Secures access to up to $30,000,000 in equity capital over the next two years, providing crucial funding for operations and growth initiatives.
• Offers flexibility to the company, allowing it to control the timing and amount of common stock sales based on its funding needs and market conditions.
• Replaces an expired financing agreement, ensuring continued access to a funding mechanism.
• The potential for a higher purchase price (90% of VWAP with a $2.00 floor) upon up-listing to NASDAQ provides an incentive for the company to achieve a higher exchange listing.

Negatives

• The pricing terms, ranging from 80% to 90% of market price/VWAP, imply significant potential dilution for existing shareholders, especially given the current likely low share price.
• The company's acknowledgment that its internal accounting controls were not effective as of the agreement date indicates a material weakness in financial reporting.
• The 4.99% beneficial ownership limit for GHS could restrict the total capital raised if the company's stock price declines significantly, as GHS would hit its ownership cap faster for a given dollar amount.

Risks

• **Dilution Risk**: The issuance of common stock at a discount to the market price, particularly if the trading price declines, will increase the number of shares outstanding and dilute the ownership interests of existing shareholders.
• **Market Conditions**: The actual amount of capital raised is dependent on market conditions and the trading price of the common stock, which could limit the company's ability to access the full $30 million commitment.
• **Shareholder Approval**: If the company up-lists to an exchange that limits share issuance without shareholder approval, it may need to obtain such approval for shares exceeding the 'Maximum Common Stock Issuance,' which could delay or limit funding.
• **Suspension/Delisting**: The agreement can be suspended if the common stock trading is suspended for two consecutive days, ceases to be quoted, or is delisted from the Principal Market, potentially cutting off access to funds.
• **Ineffective Internal Controls**: The company's management has determined that its internal accounting controls were not effective, posing a risk to the accuracy and reliability of financial reporting.

Future Outlook

The agreement provides Artificial Intelligence Technology Solutions Inc. with a flexible funding mechanism to raise up to $30 million over the next two years. This capital is intended to support general corporate and working capital needs, as well as potential acquisitions, positioning the company for continued operations and growth. The company also signals its intent to pursue an up-listing to NASDAQ or an equivalent national exchange, which would improve the pricing terms of future equity sales under this agreement.

Management Comments

• "The Board of Directors of the Company has concluded, in its good faith business judgment, and with full understanding of the implications, that such issuance is in the best interests of the Company." (Regarding the potential dilutive effect of the equity financing)
• "The Company specifically acknowledges that, subject to such limitations as are expressly set forth in the Registered Offering Transaction Documents, its obligation to issue shares of Common Stock upon purchases pursuant to this Agreement is absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership interests of other shareholders of the Company."
• "The Companys management has determined that the Companys internal accounting controls were not effective as of the date of this Agreement as further described in the SEC Documents."

Industry Context

Companies in the artificial intelligence and technology solutions sector, particularly those in growth stages or with significant R&D needs, frequently rely on equity financing to fund operations and expansion. Equity line facilities, like the one AITX has secured, are a common method for smaller or OTC-listed companies to access capital when traditional debt financing may be less accessible or more costly. The terms, including discounted pricing, reflect the risk profile and liquidity requirements often associated with such arrangements in the technology industry.

Comparison to Industry Standards

• The 80-90% of market price/VWAP discount for share purchases is a common feature in equity line or 'at-the-market' financing facilities, reflecting the liquidity provided by the investor and the inherent risk in such arrangements for companies, especially those trading on less liquid markets.
• The 4.99% beneficial ownership cap for the investor is standard practice to avoid triggering more stringent beneficial ownership reporting requirements (e.g., Schedule 13D/G filings) under SEC regulations.
• The $30 million commitment over two years is a substantial capital infusion for a company of AITX's apparent market capitalization (given the large number of outstanding shares and likely low share price), providing a significant runway for operations and strategic initiatives.
• The requirement for an effective S-1 registration statement is a standard regulatory step for continuous public offerings of securities under such agreements.
• The inclusion of a $2.00 floor price upon a NASDAQ up-list is a favorable term for the company, providing a minimum valuation for future share sales if it achieves a higher exchange listing, which is a common goal for companies on OTC markets.

Corporate Governance

Stakeholder Impact

• **Shareholders**: Existing shareholders face significant potential dilution due to the issuance of common stock at a discount to market price, which could negatively impact the value of their holdings. However, the financing provides capital for company operations, which could support long-term value.
• **Company Operations**: The agreement provides essential capital for general corporate and working capital needs, enabling the company to sustain operations, invest in growth initiatives, and pursue strategic acquisitions.
• **Creditors**: Improved liquidity and financial stability resulting from the capital raise could enhance the company's ability to meet its financial obligations to creditors.

Next Steps

• The company is required to file a Form S-1 Registration Statement with the SEC within 30 calendar days of May 27, 2025.
• The company must use its best efforts to have the S-1 Registration Statement declared effective by the SEC within 30 to 90 calendar days after filing.
• The company will continue to maintain its listing on the Principal Market and potentially pursue an up-listing to NASDAQ or an equivalent national exchange.
• The company will utilize the proceeds from the financing for general corporate and working capital purposes, and potentially for acquisitions.

Key Dates

Recommendation

Keywords

Artificial Intelligence Technology Solutions, Equity Financing, Capital Raise, SEC Filing, Form 8-K, GHS Investments, Stock Dilution, Public Company, Investment, Registration Rights, Corporate Governance, Internal Controls